SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-031739
Filing Date
2022-12-12
Accepted
2022-12-12 17:04:47
Documents
14
Period of Report
2022-12-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20221208.htm   iXBRL 8-K 36006
2 EX-3.1 exhibit31amendedandrestate.htm EX-3.1 59048
  Complete submission text file 0001628280-22-031739.txt   272559

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20221208.xsd EX-101.SCH 2156
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20221208_def.xml EX-101.DEF 14866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20221208_lab.xml EX-101.LAB 28855
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20221208_pre.xml EX-101.PRE 15463
8 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20221208_htm.xml XML 11594
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 221457817
SIC: 2834 Pharmaceutical Preparations